Ligand · CVL
CVL · 5-[4-methoxy-3-[4-[4-(1~{H}-1,2,3,4-tetrazol-5-yl) phenoxy]butoxy]phenyl]-4,4-dimethyl-2-propan-2-yl-pyrazol-3-one
CVL, 5-[4-methoxy-3-[4-[4-(1~{H}-1,2,3,4-tetrazol-5-yl) phenoxy]butoxy]phenyl]-4,4-dimethyl-2-propan-2-yl-pyrazol-3-one (C26 H32 N6 O4, 492.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- CVL
- Formula
- C26 H32 N6 O4
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CVL in 2 structures; the first of them:
- 5L9H · Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-340 · CVL A1005 · binds MET785, ASN825, TRP836, ALA837, VAL840, PHE844, MET861, GLN874 and 4 more
- 5L9H · Crystal structure of T. brucei pde-B1 catalytic domain with inhibitor npd-340 · CVL A1005 · binds MET785, ASN825, TRP836, ALA837, VAL840, PHE844, MET861, GLN874 and 4 more
Residues it binds most
PHE 4, MET 4, VAL 4, ALA 4, ASN 4, GLN 4, GLY 2, LEU 2, TRP 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.